These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 37580962)

  • 21. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
    Thakuri LS; Park CM; Kim HA; Kim HJ; Park JW; Park JC; Rhyu DY
    J Ethnopharmacol; 2024 Feb; 320():117395. PubMed ID: 37952731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
    Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH
    Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethanol Extract of
    Le TNH; Choi HJ; Jun HS
    Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SCD1 deficiency protects mice against ethanol-induced liver injury.
    Lounis MA; Escoula Q; Veillette C; Bergeron KF; Ntambi JM; Mounier C
    Biochim Biophys Acta; 2016 Nov; 1861(11):1662-1670. PubMed ID: 27477676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-tissue omics analysis discovers ten adipose genes encoding secreted proteins in obesity-related non-alcoholic fatty liver disease.
    Darci-Maher N; Alvarez M; Arasu UT; Selvarajan I; Lee SHT; Pan DZ; Miao Z; Das SS; Kaminska D; Örd T; Benhammou JN; Wabitsch M; Pisegna JR; Männistö V; Pietiläinen KH; Laakso M; Sinsheimer JS; Kaikkonen MU; Pihlajamäki J; Pajukanta P
    EBioMedicine; 2023 Jun; 92():104620. PubMed ID: 37224770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tussilagone ameliorates high-fat diet-induced hepatic steatosis by enhancing energy metabolism and antioxidant activity.
    Sun M; Li Y; Su S; Gao J; Yu L; Qi X; Liang H; Li X; Qi X; Liang Y; Zhou L; Zhang G; Li Y
    Phytother Res; 2024 May; 38(5):2099-2113. PubMed ID: 37010930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
    Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
    J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic miR-192-3p reactivation alleviates steatosis by targeting glucocorticoid receptor.
    Wang Z; Miu KK; Zhang X; Wan AT; Lu G; Cheung HH; Lee HM; Kong AP; Chan JC; Chan WY
    JHEP Rep; 2020 Dec; 2(6):100179. PubMed ID: 33134908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor.
    Dong R; Yang X; Wang C; Liu K; Liu Z; Ma X; Sun H; Huo X; Fu T; Meng Q
    Phytomedicine; 2019 Feb; 53():134-142. PubMed ID: 30668392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis.
    Bhattacharya D; Basta B; Mato JM; Craig A; Fernández-Ramos D; Lopitz-Otsoa F; Tsvirkun D; Hayardeny L; Chandar V; Schwartz RE; Villanueva A; Friedman SL
    JHEP Rep; 2021 Jun; 3(3):100237. PubMed ID: 34151243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of stearoyl-coenzyme A desaturase 1 ameliorates hepatic steatosis by inducing AMPK-mediated lipophagy.
    Zhou Y; Zhong L; Yu S; Shen W; Cai C; Yu H
    Aging (Albany NY); 2020 Apr; 12(8):7350-7362. PubMed ID: 32324591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gluten worsens non-alcoholic fatty liver disease by affecting lipogenesis and fatty acid oxidation in diet-induced obese apolipoprotein E-deficient mice.
    Aguilar EC; Fernandes-Braga W; Santos EA; Leocádio PCL; Dos Santos Aggum Capettini L; Orellano LAA; Campos PP; Lemos VS; Soares FLP; Navia-Pelaez JM; Alvarez-Leite JI
    Mol Cell Biochem; 2024 Jun; 479(6):1335-1347. PubMed ID: 37402020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
    Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
    Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease.
    Liu C; Zhou B; Meng M; Zhao W; Wang D; Yuan Y; Zheng Y; Qiu J; Li Y; Li G; Xiong X; Bian H; Zhang H; Wang H; Ma X; Hu C; Xu L; Lu Y
    J Hepatol; 2021 Jul; 75(1):150-162. PubMed ID: 33548387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ablation of prolactin receptor increases hepatic triglyceride accumulation.
    Shao S; Yao Z; Lu J; Song Y; He Z; Yu C; Zhou X; Zhao L; Zhao J; Gao L
    Biochem Biophys Res Commun; 2018 Apr; 498(3):693-699. PubMed ID: 29524401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LY6D is crucial for lipid accumulation and inflammation in nonalcoholic fatty liver disease.
    Lee J; Kim H; Kang YW; Kim Y; Park MY; Song JH; Jo Y; Dao T; Ryu D; Lee J; Oh CM; Park S
    Exp Mol Med; 2023 Jul; 55(7):1479-1491. PubMed ID: 37394588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shenge Formula attenuates high-fat diet-induced obesity and fatty liver via inhibiting ACOX1.
    Shang Z; Gao Y; Xue Y; Zhang C; Qiu J; Qian Y; Fang M; Zhang X; Sun X; Kong X; Gao Y
    Phytomedicine; 2024 Jan; 123():155183. PubMed ID: 37992491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic
    Lee YH; Jang HJ; Kim S; Choi SS; Khim KW; Eom HJ; Hyun J; Shin KJ; Chae YC; Kim H; Park J; Park NH; Woo CY; Hong CH; Koh EH; Nam D; Choi JH
    Elife; 2021 Dec; 10():. PubMed ID: 34964438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.